Literature DB >> 10469498

Colorimetric and fluorimetric microplate assays for legumain and a staining reaction for detection of the enzyme after electrophoresis.

H T Johansen1, C G Knight, A J Barrett.   

Abstract

The cysteine endopeptidase legumain was recently discovered in mammalian cells, predominantly localized in the lysosomal system where it is believed to contribute to antigen processing for MHC class II. Here we describe rapid assay procedures for the enzyme in 96-well microplates with two substrates, a novel compound, succinyl-Ala-Ala-Asn-4-methoxy-2-naphthylamide, and benzyloxycarbonyl-Ala-Ala-Asn-4-methyl-7-coumarylamide. Both substrates are suitable for fluorimetric assays, but the naphthylamide also allows colorimetric detection of legumain activity, since the released 4-methoxy-2-naphthylamine gives a red product when coupled with the Fast Garnet color reagent. We show that the naphthylamide substrate can be used to visualize active legumain after electrophoresis in polyacrylamide gel. Both substrates provide assays that are reproducible and sufficiently sensitive to allow the assay of legumain in crude samples such as tissue homogenates, although the coumarylamide is the more sensitive. The specificity of both assay methods for legumain was verified by the lack of inhibition by E-64 and total inhibition by egg white cystatin. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10469498     DOI: 10.1006/abio.1999.4221

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  7 in total

1.  Counter Selection Substrate Library Strategy for Developing Specific Protease Substrates and Probes.

Authors:  Marcin Poreba; Rigmor Solberg; Wioletta Rut; Ngoc Nguyen Lunde; Paulina Kasperkiewicz; Scott J Snipas; Marko Mihelic; Dusan Turk; Boris Turk; Guy S Salvesen; Marcin Drag
Journal:  Cell Chem Biol       Date:  2016-07-28       Impact factor: 8.116

2.  Simvastatin inhibits glucose metabolism and legumain activity in human myotubes.

Authors:  Robert Smith; Rigmor Solberg; Linn Løkken Jacobsen; Anette Larsen Voreland; Arild Christian Rustan; G Hege Thoresen; Harald Thidemann Johansen
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

3.  Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis.

Authors:  Abbas Jafari; Diyako Qanie; Thomas L Andersen; Yuxi Zhang; Li Chen; Benno Postert; Stuart Parsons; Nicholas Ditzel; Sundeep Khosla; Harald Thidemann Johansen; Per Kjærsgaard-Andersen; Jean-Marie Delaisse; Basem M Abdallah; Daniel Hesselson; Rigmor Solberg; Moustapha Kassem
Journal:  Stem Cell Reports       Date:  2017-02-02       Impact factor: 7.765

4.  Sepsis causes right ventricular myocardial inflammation independent of pulmonary hypertension in a porcine sepsis model.

Authors:  Soeren Erik Pischke; Siv Hestenes; Harald Thidemann Johansen; Hilde Fure; Jan Frederik Bugge; Andreas Espinoza; Helge Skulstad; Thor Edvardsen; Erik Fosse; Tom Eirik Mollnes; Per Steinar Halvorsen; Erik Waage Nielsen
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

5.  Cystatin E/M suppresses legumain activity and invasion of human melanoma.

Authors:  Jon J Briggs; Mads H Haugen; Harald T Johansen; Adam I Riker; Magnus Abrahamson; Øystein Fodstad; Gunhild M Maelandsmo; Rigmor Solberg
Journal:  BMC Cancer       Date:  2010-01-15       Impact factor: 4.430

6.  PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells.

Authors:  Chaido Stathopoulou; Arunakumar Gangaplara; Grace Mallett; Francis A Flomerfelt; Lukasz P Liniany; David Knight; Leigh A Samsel; Rolando Berlinguer-Palmini; Joshua J Yim; Tania C Felizardo; Michael A Eckhaus; Laura Edgington-Mitchell; Jonathan Martinez-Fabregas; Jinfang Zhu; Daniel H Fowler; Sander I van Kasteren; Arian Laurence; Matthew Bogyo; Colin Watts; Ethan M Shevach; Shoba Amarnath
Journal:  Immunity       Date:  2018-07-24       Impact factor: 31.745

7.  Nuclear legumain activity in colorectal cancer.

Authors:  Mads H Haugen; Harald T Johansen; Solveig J Pettersen; Rigmor Solberg; Klaudia Brix; Kjersti Flatmark; Gunhild M Maelandsmo
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.